Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Cerebral

My doctor diagnosed me with ADHD – so how did my phone find out?

Targeted ads started selling me services to help manage my symptoms – for a price. The law must offer more protection, says Guardian news reporter Sarah Marsh

The Guardian - UK

Patients can't find Adderall in shortage

Some are questioning the DEA’s role in allocating drug supply as the medication crisis deepens

Salon

When it comes to adult ADHD, the US medical system is falling behind

As more people seek diagnosis and treatment, the system is unable to serve them, and social media is filling in those gaps

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

Pandemic telehealth was a boon to people with psychiatric conditions — what happens when it ends?

Changes to psychiatric telehealth in the coming months may make it harder for people to access medication.

Inverse

‘The worst it’s ever been’: mysterious US Adderall shortage puts ADHD patients at risk

In recent months, patients have reported problems filling nearly every type of ADHD medication prescription – and no one seems to know why

The Guardian - US

Simone Biles and mental health start-up Cerebral end endorsement partnership

The split comes seven months after federal investigators issued a subpoena to the firm for its prescriptions of controlled substances

The Guardian - US

What TikTok does to your mental health: ‘It’s embarrassing we know so little’

Nearly six in 10 teenagers count themselves as daily users of the app yet little is known about the impacts on the brain

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

Yes, there's an Adderall shortage. Experts say high demand and the pandemic are fueling it

Many are quick to point fingers at online mental health startups that launched during the beginning of the pandemic. But there’s more at play, a pharmacists tells Fortune.

Fortune

Digital mental health companies draw scrutiny and growing concerns

When Pat Paulson’s son told her he was feeling anxious and depressed at college, Paulson went through her Blue Cross Blue Shield provider directory and started calling mental health therapists. No providers in the Wisconsin city where her son’s university is located had openings. So she bought a monthly subscription…

Tribune News Service

Morning Brief: Top Financial Stories Dominating on Wednesday, June 15

Reuters Warner Bros Discovery To Undergo Major Global Ad Sales Team Restructuring

Benzinga

Softbank-Backed Mental Health Startup Cerebral Under FTC Scrutiny: WSJ

The Federal Trade Commission (FTC) has begun investigating mental-health startup Cerebral Inc on its potential engagement in unfair practices related to advertising or marketing of services.

Benzinga

TikTok trends or the pandemic? What’s behind the rise in ADHD diagnoses

By 2016, the reported incidence of adult ADHD rose by 123% in the US – increases in stimulant medication prescriptions suggest its rise continues

The Guardian - US

CVS Stops Filling Controlled Substance Prescriptions From Two Telehealth Firms: Report

CVS Health Corp. (NYSE: CVS) has stopped filling prescriptions for controlled substances requested by clinicians from the telehealth startup companies Cerebral Inc. and Done Health.

Benzinga

Morning Brief: Top Financial Stories Dominating on Wednesday, May 25

Reuters Ford To Pay $19.2M In Multi-State Settlement For False Advertising Claims

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

CVS Health To Stop Filling Controlled Substances Prescriptions For Cerebral, Done Health

CVS Health Corp (NYSE: CVS) will stop

Input

Cerebral realizes pushing benzos over social media is bad, actually

Turns out hawking controlled substances online may not be the best form of treatment.

Axios

The trouble with telehealth prescriptions

Cerebral told clinicians it will stop prescribing Adderall and other controlled substances to treat ADHD for new patients.

Input

Controversial ADHD startup Cerebral stops prescribing Adderall

The company you've seen all over your TikTok feed is also being investigated by the DEA.

Get all your
news in one place.

100’s of premium titles.
One news app.

Axios

Telehealth startup Cerebral will stop prescribing Adderall for new ADHD patients

The company says it will continue to prescribe controlled substances for other conditions.

Input

TikTok helped turn a sketchy telehealth company into an empire

A new exposé from Bloomberg Businessweek lays out the trouble with telehealth startup, Cerebral, and how social media is making matters worse.

Benzinga

Psyched: First Australian Psych Company On Nasdaq, Utah's Psychedelics Bill, LSD Vs. Psilocybin Study Unprecedented Results

On the legislative front of the psychedelics space, a new bill meant to study the therapeutic effects of psychedelic substances received full approval in both Utah chambers, standing out from among dozens of measures currently circulating in legislatures across several U.S. states. Psychedelic science also took an important step forward with the publication…

Benzinga

Field Trip And Cerebral Partner To Bring Together Teletherapy, Telepsychiatry, And Psychedelic-Assisted Therapy

Field Trip Health Ltd. (NASDAQ:FTRP) (TSX:FTRP) and Cerebral are launching a partnership where Cerebral clinicians can refer qualified clients to Field Trip Health's ketamine assisted therapy, while Field Trip will connect potential clients seeking general psychiatry and teletherapy services to Cerebral. This end-to-end solution will provide personalized treatment solutions for…

Reason

Instagram Bans Healthy Eating Ads for Promoting 'Negative Self-Perception'

Plus: The ERA returns (again), Rep. Nancy Mace's marijuana mission, and more...

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.